Cellromax Science Co., Ltd. (KOSDAQ:471820)
South Korea · Delayed Price · Currency is KRW 5,450.00
0.00 (0.00%)
At close: Feb 19, 2026
Cellromax Science Market Cap
Cellromax Science has a market cap or net worth of 60.69 billion as of February 20, 2026. Its market cap has increased by 2.59% in one year.
Market Cap
60.69B
Enterprise Value
55.48B
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
5,450.00
Market Cap Chart
Since December 13, 2024, Cellromax Science's market cap has decreased from 92.69B to 60.69B, a decrease of -34.53%. That is a compound annual growth rate of -30.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 19, 2026 | 60.69B | -16.15% |
| Dec 30, 2025 | 72.38B | 26.47% |
| Dec 30, 2024 | 57.23B | -38.25% |
| Dec 13, 2024 | 92.69B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| ALT Co., Ltd. | 97.57B |
| GITSN | 96.93B |
| Black Yak I&C Co.,Ltd | 91.69B |
| BBIA Co., Ltd. | 89.30B |
| Laseroptek | 73.84B |
| JNB Co., Ltd. | 64.14B |
| Korea No.14 Special Purpose Acquisition | 59.40B |
| Mirae Asset Vision Special Purpose Acquisition 2 Company | 46.92B |